Browsing: News

Boehringer Ingelheim showcases The Unwearable Collection™ in collaboration with Bart Hess to raise awareness about generalized pustular psoriasis (GPP).

Medical Channel Asia presents the weekly Asian medical news bulletin, bringing you essential healthcare news from across the region. This…

A recent study revealed that it provides a unique cognitive boost that surpasses what can be achieved with caffeine alone.

The FDA has recently endorsed Opill, a new over-the-counter birth control pill, marking a historical turning point in contraception access.

Discover the highlights of the 25th World Congress of Dermatology in Singapore, featuring thousands of dermatologists and industry representatives from over 130 countries.

Mandopop diva Coco Lee was born into an ordeal that continued to be a part of her life until her last breath. She has been plagued with medical issues throughout her life. Medical misalignment during birth led to her left leg being dislocated, leaving her with a permanent limp. Despite warnings from doctors, Coco refused to let her medical condition deter her passion for performing and dancing.

Singapore is moving towards a healthcare strategy that focuses on providing preventive solutions in a bid to combat an ageing population. 

In a remarkable testament to the power of strategic healthcare planning, a 76-year-old Singaporean today enjoys a health status similar to an average 65-year-old globally, bested only by Japan. This remarkable achievement comes from three decades of meticulous planning and investments in healthcare, with a blueprint laid out in the White Paper on Affordable Healthcare in 1993.

In an unprecedented move, Moderna, a biotech firm based in Massachusetts, USA, has struck a landmark deal with Chinese officials to research, develop and manufacture messenger RNA (mRNA) medicines in China. 

In a bid to combat plastic waste while providing affordable healthcare, this clinic in Indonesia has adopted a trash-for-healthcare programme.

The FDA is poised to make a decision on granting approval to Leqembi – the first drug to show promise in slowing Alzheimer’s disease.